ACTRN12620000090910
Completed
未知
Development of less-invasive predictive biomarkers of immunotherapy treatment in patients with non-small cell lung (NSCLC) and genitourinary cancers and its impact on overall survival
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Ingham Institute for Applied Medical Research
- Enrollment
- 48
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically or cytologically confirmed non\-small cell lung cancer, bladder cancer, kidney cancer
- •Must be commencing immunotherapy for NSCLC, renal or bladder cancer
Exclusion Criteria
- •Not commencing immunotherapy
- •No consent signed
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Prospective evaluation of non-invasive biomarkers of kidney function and musculoskeletal status with checkpoint inhibitor therapyto prospectively evaluate kidney function and musculoskeletal status in patients receiving a checkpoint inhibitor therapyDRKS00030999niversitätsmedizin Göttingen200
Completed
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000010140Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences216
Recruiting
Not Applicable
Study for new biomarker development in the prediction of prognosis of renal function in chronic kidney diseaseJPRN-UMIN000014093Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences512
Completed
Not Applicable
Study for new biomarker development in the prediction of renal anemia progression in chronic kidney diseaseJPRN-UMIN000008699Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences90
Recruiting
Not Applicable
Research for early detection of adverse events of immune checkpoint inhibitorsung cancerJPRN-UMIN000044022Hokkaido University of Science Faculty of Pharmaceutical Sciences25